In the cannabis industry, innovation and compliance are critical to success, and few understand this better than Marc Beginin. With over 20 years of experience as an entrepreneur and attorney in the field, Marc has consistently been at the forefront of advancing cannabis extraction technologies.
As the founder of Prodigy Processing Solutions, Marc is pioneering GMP-compliant hydrocarbon extraction systems that set new standards for safety, quality, and efficiency.
Marc Beginin is a seasoned entrepreneur and attorney with over 20 years of experience in the cannabis industry. In 2014, he founded Precision Extraction Solutions, a company that revolutionized cannabis extraction technology and was acquired by Agrify Corporation (NASDAQ: AGFY) in 2021 for over $50 million.
In 2023, Marc launched Prodigy Processing Solutions, which offers GMP-compliant hydrocarbon extraction systems designed to meet the highest safety, quality, and efficiency standards in cannabis processing.
Prodigy’s pharma-ready solutions help operators navigate evolving regulations, from state compliance to federal standards. A Wharton alum, Marc is known for his bold leadership and innovative strategies, including a high-profile hostile takeover attempt of Agrify in 2022.
In this exclusive interview with Ganjly, Marc discusses the milestones, challenges, and future of cannabis extraction technology, shedding light on Prodigy’s role in shaping the industry’s trajectory.
Ganjly: What does it mean for Prodigy to be the first hydrocarbon cannabis extraction equipment approved for use in New York City, and how does this milestone position your company in the broader cannabis market?
Marc Beginin: Being the first hydrocarbon cannabis extraction equipment approved for use in New York City is a significant milestone for Prodigy, underscoring our commitment to engineering excellence, regulatory compliance, and innovation. This approval demonstrates our ability to meet the highest safety standards in one of the world’s most regulated markets, not only validates the quality and safety of our equipment but also strengthens our ability to support operators in navigating complex regulations and delivering premium cannabis products.
Ganjly: Why was ProXtracts’ choice of Prodigy’s GMP-compliant hydrocarbon extraction equipment significant for securing New York’s first Tier 1 Cannabis Processor License?
Marc Beginin: ProXtracts’ choice of Prodigy’s GMP-compliant hydrocarbon extraction equipment was pivotal in securing New York’s first Tier 1 Cannabis Processor License because it demonstrated their commitment to the highest standards of safety, quality, and regulatory compliance. Prodigy’s adherence to globally recognized GMP standards not only ensured ProXtracts met the rigorous requirements set by New York regulators but also positioned them to produce premium, safe, and consistent cannabis products at scale. This collaboration highlights the critical role Prodigy plays in enabling processors to navigate complex regulatory landscapes with confidence and to deliver safe products to their customers.
Ganjly: Hydrocarbon extraction is considered the gold standard for cannabis oil production. What makes this method superior, and how does Prodigy ensure its safety and compliance in such a heavily regulated industry?
Marc Beginin: Hydrocarbon extraction is considered the gold standard for cannabis oil production due to its unparalleled ability to efficiently extract a full spectrum of cannabinoids, terpenes, and other desirable compounds while maintaining the integrity of the plant material. This method allows for the production of high-quality, versatile products such as live resin, shatter, and other premium concentrates. At Prodigy, we ensure safety and compliance by designing our equipment to meet and exceed GMP standards, incorporating advanced safety features like pressure control systems, closed-loop technology, and rigorous material certifications, giving operators confidence in both performance and regulatory adherence in even the most heavily regulated markets.
Ganjly: With Prodigy’s equipment meeting FDA requirements, how do you see your technology helping cannabis companies prepare for potential federal legalization and stricter national regulations?
Marc Beginin: Prodigy’s equipment, designed to meet FDA requirements, positions cannabis companies to seamlessly transition into a federally regulated market. Our GMP-compliant technology ensures that operators can adhere to the strict standards expected in pharmaceutical and food-grade manufacturing, which are likely to become the baseline under federal legalization. By investing in Prodigy’s extraction systems, cannabis businesses future-proof their operations, enabling them to produce consistent, high-quality products that meet the demands of stricter national and international regulations. This not only provides a competitive edge but also opens opportunities to collaborate with pharmaceutical companies and enter new markets as the industry evolves.
Ganjly: GMP compliance is a cornerstone of Prodigy’s philosophy. Can you explain why genuine GMP compliance is essential, and what distinguishes Prodigy’s approach to achieving it?
Marc Beginin: GMP compliance is essential because it ensures the safety, quality, and consistency of cannabis products, which are critical for consumer trust and regulatory approval, especially as the industry moves closer to federal legalization. At Prodigy, genuine GMP compliance goes beyond checking boxes; it’s embedded in every aspect of our equipment design and manufacturing process. We provide complete documentation packages, third-party certifications, and systems built to meet stringent international standards, enabling operators to align with FDA and global regulatory expectations. What sets us apart is our turnkey approach—offering not just equipment but also the expertise to help our clients navigate complex compliance requirements, positioning them for long-term success in a heavily regulated market.
Ganjly: The New York cannabis market has reached over $1 billion in sales since 2022. How do partnerships like the one with ProXtracts contribute to shaping the future of consumer safety and product quality in such a fast-growing industry?
Marc Beginin: Partnerships like the one with ProXtracts play a vital role in shaping the future of consumer safety and product quality in New York’s rapidly growing cannabis market. By choosing Prodigy’s GMP-compliant hydrocarbon extraction equipment, ProXtracts has set a new standard for producing high-quality, consistent, and safe cannabis products. These collaborations not only ensure compliance with stringent regulations but also drive innovation and transparency in the industry. As the market surpasses $1 billion in sales, such partnerships demonstrate how prioritizing consumer safety can elevate the industry as a whole.
Ganjly: You’ve emphasized the need for stronger GMP guidelines from the New York Office of Cannabis Management (OCM). What gaps currently exist in these regulations, and how could addressing them benefit both businesses and consumers?
Marc Beginin: The current GMP guidelines from the OCM lack the specificity and rigor needed to fully align with pharmaceutical-grade standards, creating potential inconsistencies in product quality and safety across the market. Key gaps include a lack of detailed requirements for equipment validation, process controls, and comprehensive documentation for traceability. Strengthening these guidelines would provide clearer benchmarks for businesses, ensuring a level playing field and fostering greater compliance. For consumers, stricter GMP standards would enhance safety, consistency, and trust in the products they purchase, ultimately driving the long-term growth and credibility of New York’s cannabis industry.
Ganjly: ProXtracts’ processing license allows for toll processing services. How does Prodigy’s equipment enable processors to provide high-quality products to cultivators and manufacturers across the state?
Marc Beginin: Prodigy’s equipment empowers processors like ProXtracts to deliver high-quality products to cultivators and manufacturers by combining cutting-edge hydrocarbon extraction technology with GMP-compliant designs. Our systems are engineered for efficiency, precision, and scalability, enabling toll processors to consistently produce premium concentrates, distillates, and isolates that meet the highest standards of safety and purity. Features like closed-loop extraction, advanced filtration, and inline winterization ensure that every batch is of superior quality, while our comprehensive support and documentation packages help processors maintain compliance with state regulations. This allows processors to operate as trusted partners, meeting the diverse needs of cultivators and manufacturers across New York.
Ganjly: What role do you see Prodigy playing in the evolution of cannabis extraction technology, both in New York and globally, as the industry continues to grow and mature?
Marc Beginin: Prodigy is at the forefront of cannabis extraction technology, driving innovation and setting new benchmarks for safety, quality, and efficiency. In New York, our GMP-compliant systems help processors meet strict state standards while preparing for future federal regulations. Globally, as the industry prepares for the rescheduling of cannabis to Schedule III, Prodigy plays a critical role in bridging the gap between cannabis extraction and pharmaceutical manufacturing. Our expertise and technology enable operators to produce pharmaceutical-grade products, including active pharmaceutical ingredients (APIs), ensuring they are ready to thrive in federally regulated markets.
Ganjly: Looking ahead, what innovations or advancements can we expect from Prodigy Processing Solutions as it continues to set benchmarks in cannabis extraction technology?
Marc Beginin: Looking ahead, Prodigy Processing Solutions will continue to push the boundaries of cannabis extraction technology with innovations focused on efficiency, scalability, and pharmaceutical-grade quality. We are actively developing next-generation systems that streamline processes, reduce operational costs, and deliver unparalleled consistency for producing active pharmaceutical ingredients (APIs) and other premium cannabis products. Our emphasis on automation, sustainability, and enhanced compliance tools will further empower operators to meet evolving regulatory standards. As the industry advances, Prodigy remains committed to setting new benchmarks that not only elevate product quality but also position our partners for success in both the cannabis and pharmaceutical sectors.
Marc Beginin’s visionary leadership and relentless pursuit of excellence continue to redefine what is possible in the cannabis extraction sector. Through Prodigy Processing Solutions, Marc is not only preparing operators for the complexities of federal legalization but also driving innovations that position cannabis as a pharmaceutical-grade industry.
As the cannabis market matures, it’s clear that Prodigy’s commitment to safety, compliance, and quality will leave a lasting impact, ensuring operators are equipped to meet the demands of an evolving regulatory landscape. We thank Marc for sharing his insights and look forward to witnessing Prodigy’s contributions to the industry’s growth and success.
